Hadi Dourra MD in Redford Township, Michigan

Home Michigan Redford Township

Hadi Dourra MD has Internal Medicine listed as his primary medical specialty. Their primary office is listed as: 27144 Joy Rd in Redford Township, Michigan. They attended Wayne State University School Of Medicine and graduated in 2004 (giving them around 19 years of experience).

Hadi A Dourra MD Office Phone and Directions

Hadi Dourra MD
27144 Joy Rd
Redford Township, Michigan 48239
-

Get mobile directions from current location:

or enter a starting address:

Healthcare Info for Hadi Dourra MD

Hospital Affiliations Include:
GARDEN CITY HOSPITAL
BEAUMONT HOSPITAL - DEARBORN
ST MARY MERCY HOSPITAL
BEAUMONT HOSPITAL - WAYNE

Medical School: Wayne State University School Of Medicine
Graduation Year: 2004
The Primary Medical Specialty for Hadi Dourra MD is listed as: Internal Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 19
PAC (PECOS ID)#: 5193823409
NPI #: 1003975517
NPI Created On: 12/08/2006
NPI Last Updated Listed as: 10/28/2019
Primary Taxonomy Code: 208M00000X
First Listed License State (can have more than one): MI
License Number: 4301084360
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Michigan, Inc.
Humana
Total Health Care USA, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Automated urinalysis test
Hemoglobin a1c level
Vaccine for influenza for injection into muscle
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital observation or inpatient care moderate severity, 50 minutes per day'
Hospital discharge day management, more than 30 minutes
Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
Administration of influenza virus vaccine

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788929255

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788929257

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788929259

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788929261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788929263

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813500445

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794376349

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794376351

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794376353

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROENTEROLOGY

Name of Drug #1: LINZESS

Open Associated Drug #1: 0456-1201-30

Drug or Biological: Drug

Product Category #2: ENDOCRINOLOGY

Name Of Drug #2:: CREON

Associated Drug #2: 0032-3016-13

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794376355

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31